Overview

Mohammad K. Khan MD, PhD, DABR, is a board certified radiation oncologist specializing in the treatment of leukemia, lymphoma, melanoma, skin cancer (basal, squamous and Merkel cell), multiple myeloma and pediatric cancer. He treats patients at Winship Cancer Institute of Emory University.

As the Department of Radiation Oncology's Vice Chair for Education, Dr. Khan works to complement and extend the departments educational efforts beyond its residency programs.

Dr. Khan is engaged in a wide variety of cancer related research, including designing new clinical trials, enrolling patients on existing trials, developing patient databases to look at treatment outcomes, and engineering new mathematical and physics solutions to improve existing technologies such as IMRT (Intensity Modulated Radiotherapy) and IGRT (Image Guided Radiotherapy).

Dr. Khan has collectively authored numerous abstracts, manuscripts, commentaries, and book chapters. He has presented at national and international conferences and is a member of the American Brachytherapy Society, American Society for Therapeutic Radiation Oncology and American Society of Clinical Oncology. He is a Fellow of the American College of Radiation Oncology and American College of Radiology.

Dr. Khan serves as a board member of the Georgia Radiological Society, is a vice chair of the Radiation Safety Committee for Human Use at Emory, is an active member of the ACRIN/ECOG melanoma committee. He also serves on the radiation oncology exam committee of the American Board of Radiology where he is involved developing maintenance of certification exam questions, initial certification exam questions, and oral exam questions as they relate to the management of lymphoma, leukemia, and myeloma patients.

Dr. Khan fluently speaks English, Urdu, Hindi and is familiar with Spanish and Arabic.

Dr. Khan received his MD and PhD from the University of Tennessee, Memphis. He also received his MS in Nuclear Engineering from University of Tennessee, along with a BS, Summa Cum Laude degree in Biology and a BS, Summa Cum Laude degree in Nuclear Engineering. He did his residency training in radiation oncology at the Cleveland Clinic, Cleveland, OH. He completed a fellowship in ABS Prostate Bracytherapy at the Seattle Prostate Institute and an internship in medicine and surgery at the Cleveland Clinic. His graduate research focused on the use of innovative imaging technologies, such as PET and MRI, to improve radiation treatment planning for emerging cancer therapeutics such as boron neutron capture therapy for patients with malignant brain tumors.

During his residency training, he received several academic accolades including the Roentgen Resident/Fellow Research Award for Outstanding Radiological Research, the Scott Hamilton CARES Initiative Research Grant to fund a prospective phase I prostate cancer IGRT study, American College of Radiation Oncology Travel Award, American Brachytherapy Society Fellowship Award, and the American Society of Therapeutic Radiation Oncology Translation and Imaging Symposium Travel Award.

Academic Appointment

• Professor, Department of Radiation Oncology, Emory University School of Medicine
• Adjunct Research Assistant Professor, Department of Nuclear Engineering, University of Tennessee
• Adjunct Assistant Professor, Department of Nuclear Engineering, Georgia Institute of Technology

Education

Research